세계 혈관 폐쇄 기기 시장 규모는 2023년 11억 1,000만 달러, 2030년까지 15억 9,000만 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 6.18% 성장할 것으로 예상됩니다. 심근경색과 같은 심혈관 질환의 유병률 증가, 비만 및 고혈압과 같은 심혈관 질환과 관련된 위험 요소의 유병률 증가, 노인 인구 증가, 저침습적 시술의 인기 급상승 등의 요인이 혈관 폐쇄 기기 시장을 견인할 것으로 예상됩니다.
혈관폐쇄장치 시장 역학
혈관 폐쇄 기기 시장은 전 세계 심혈관 질환의 유병률 증가로 인해 수요 증가를 보이고 있습니다. 세계보건기구(WHO)(2023)가 제공한 데이터에 따르면, 심혈관 질환(CVDs)은 전 세계 주요 사망 원인으로 매년 약 1,790만 명의 목숨을 앗아가는 것으로 추정됩니다. 또한, WHO 데이터에 따르면 심혈관 질환 관련 사망 5건 중 4건 이상이 뇌졸중과 심장마비로 인한 사망이며, 이 중 3분의 1은 70세 미만의 젊은 연령층에서 발생하는 것으로 추정됩니다.
유럽심장학회(ESC)(2023)의 데이터에 따르면, 매년 유럽에서 심혈관 질환(CVD)은 390만 명의 사망원인이 되고 있으며, 유럽연합(EU)에서는 180만 명 이상이 사망합니다. 유럽에서는 전체 사망자의 약 45%, 유럽연합에서는 37%를 차지합니다.
일반적인 심혈관 질환에는 관상동맥성 심장질환, 뇌졸중, 말초심장질환, 심부전 등이 있습니다.
또한, 앉아서 생활하는 등 건강에 좋지 않은 생활 습관은 모든 연령대에서 비만 유병률을 증가시키고 있습니다. 세계보건기구(WHO)가 발표한 비만 팩트시트(2023)에 따르면, 18세 이상 성인 19억 명 이상이 과체중이며, 그 중 6억 5,000만 명이 비만인 것으로 나타났습니다. 비만은 심혈관 질환 발병의 주요 위험 요인 중 하나로 보입니다. 비만도가 높아지면 혈압이 상승하고 심혈관 질환의 발병률이 높아지는 것으로 알려져 있습니다.
따라서 심혈관 질환의 유병률 증가 및 관련 위험 요소는 혈관 조영술 및 혈관 성형술과 같은 진단 및 치료 목적의 중재적 심장 시술에 대한 수요 증가로 이어지고 있습니다. 이에 따라, 접근 부위를 시간 효율적으로 봉합하는 데 도움이 되는 혈관 폐쇄 기기에 대한 수요가 증가하고 있습니다.
또한, 새로운 개발과 같은 최소침습적 시술의 인기가 높아짐에 따라 VCD의 사용은 계속 증가하고 있습니다. 현재 추세는 대구경 대퇴동맥 절개 부위를 안전하고 효율적으로 폐쇄할 수 있는 장치 개발에 초점을 맞추었습니다. 경카테터 대동맥 판막 복원술과 경피적 혈관 내 동맥류 복원술이 보편화됨에 따라 간단하면서도 효과적인 VCD를 개발하고 그 유용성을 입증할 수 있는 큰 동기를 부여하고 있습니다.
그러나 혈관폐쇄장치에 따른 합병증과 큰 직경의 천자 폐쇄에 대한 혈관폐쇄장치의 한계는 혈관폐쇄장치 시장의 성장에 대한 일정한 억제요인으로 작용할 수 있습니다.
혈관폐쇄장치 시장 부문 분석
혈관 폐쇄 기기 시장의 제품 부문에서는 혈관 폐쇄 기기 시장의 동적 근사치 카테고리가 혈관 폐쇄 기기 시장에서 큰 매출 점유율을 차지할 것으로 예상됩니다. 이는 혈류를 차단하는 데 시간이 걸리는 정적 근사치에 비해 즉각적인 혈관 폐쇄를 제공한다는 점에서 정적 근사치보다 우수한 품질을 제공하기 때문입니다. 동적 근사치는 봉합 기반, 클립 기반, 압박 보조 장치로 세분화됩니다.
또한, 정적 근사치 카테고리는 생체 재료 기반 장치의 인기가 높아짐에 따라 예측 기간 동안 혈관 폐쇄 기기에서 더 빠른 성장을 보일 것으로 예상됩니다.
북미가 전체 혈관 폐쇄 기기 시장을 독점할 것으로 예상됩니다.
북미는 전체 지역 중 혈관 폐쇄 기기 시장에서 가장 큰 시장 점유율을 차지할 것으로 예측됩니다. 북미가 압도적인 시장 점유율을 차지할 것으로 예상되는 이유는 심혈관 질환 및 관련 위험 요소의 높은 유병률, 노인 인구 증가, 질병 관리에 대한 높은 인식, 그리고 이러한 장치를 구매할 수 있는 능력 등이 있기 때문입니다.
이 보고서는 세계 혈관폐쇄장치 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.
Vascular Closure Devices Market By Product Type (Active Approximators [Suture-Based, Clip-Based, and Assisted Compression Devices] and Passive Approximators [Sealant-Or-Gel-Based And Bioabsorbable Plugs], and Others), By Access (Femoral And Radial), and By End User (Hospitals & Clinics, Ambulatory Surgical Centers, ad Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of cardiovascular diseases such as heart strokes and increasing prevalence of obesity.
Global Vascular Closure Devices Market was valued at USD 1.11 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030 to reach USD 1.59 billion by 2030. Factors such as the growing prevalence of cardiovascular disorders such as heart strokes, rising prevalence of risk factors associated with the cardiovascular diseases such as obesity and hypertension, increasing geriatric population, and the surge in the popularity of minimally invasive procedures, are expected to drive the vascular closure devices market.
Vascular Closure Devices Market Dynamics:
The vascular closure devices market is witnessing an increase in demand due to the rising prevalence of cardiovascular diseases the globe. As per the data provided by the World Health Organization (2023), cardiovascular diseases (CVDs) are the leading cause of death across the globe, accounting for an estimated 17.9 million loss of lives each year. Furthermore, the same data by the WHO presented that over four out of five deaths related to cardiovascular diseases list strokes and heart attacks as the main cause, and one-third of these deaths are estimate to occur prematurely in people below 70 years of age.
According to the data provided by the European Society for Cardiology (ESC) (2023), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the European Union.
Some of the common cardiovascular diseases include coronary heart disease, strokes, peripheral heart disease, and heart failure among others.
Furthermore, the unhealthy lifestyle such as sedentary lifestyle has led to the increased prevalence of obesity in the world across all age groups. According to the factsheet provided by the World Health Organization on Obesity (2023), over 1.9 billion adults in the age group of 18 and above were overweight, out of which 650 million people were obese. Obesity is considered as one of the major risk factors for the development of cardiovascular diseases. It has been observed that the increase body mass index results in the increase in blood pressures and rates of cardiovascular diseases.
Therefore, the increase in the prevalence of cardiovascular diseases and the associated risk factors have led to the growth in demand for interventional cardiac procedures for both diagnostic and treatment purposes such as angiography and angioplasty. Therefore, the need for vascular closure devices is witnessing an increase as they help in the sealing of the access site in a time-efficient manner.
Moreover, the rising popularity of minimally invasive procedures such as new developments continue to advance the utilization of VCDs. Current trends are focused on developing devices that can safely and efficiently close large-caliber femoral arteriotomies. As trans-catheter aortic valve repair and percutaneous endovascular aneurysm repair become commonplace, there will be tremendous incentive to develop and prove the utility of a simple but effective VCD.
However, complications associated with the vascular closure devices, and limitations of vascular closure devices in closing large bore punctures may prove to be certain restraints to the vascular closures devices market growth.
Vascular Closure Devices Market Segment Analysis:
Vascular Closure Devices Market by Product Type (Active Approximators [Suture-Based, Clip-Based, and Assisted Compression Devices] and Passive Approximators [Sealant-Or-Gel-Based and Bioabsorbable Plugs], and Others), by Access (Femoral And Radial), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the vascular closure devices market, the active approximators category of the vascular devices is expected to amass the significant revenue share in the vascular closure devices market. This can be attributed to their advantageous quality over passive approximators in terms of providing immediate vascular closure compared to passive approximators that take time in ceasing the blood flow. The active approximators are further segmented into suture-based, clip-based, and compression-assist devices.
Furthermore, the passive approximators category is predicted to witness a faster growth in the vascular closure devices in the forecast period due to the growing popularity of the biomaterial-based devices.
North America is expected to dominate in the overall Vascular Closure Devices Market:
Among all the regions, North America is expected to account for the significant market share in the vascular closure devices market. North America is predicted to account for the dominant market share because of the high prevalence of cardiovascular diseases and associated risk factors, rising population of the elderly, high awareness among people regarding disease management and ability to afford such devices and among other factors in the region.
Heart diseases in an umbrella term which encompasses numerous indications such as acute coronary syndrome, atherosclerosis, congestive heart failure among others. As per the information provided by the Centers for Disease Control and Prevention (2023), some of the key risk factors associated with heart diseases are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.
Furthermore, as per the data provided by the Canadian Institute for Health Information, in 2020, about 2.4 million Canadians suffered from heart disease and was considered to be the second leading cause of death in the country. Therefore, this may result in an increase in the patient population suffering from heart diseases which may in turn increase in the demand for cardiac interventional procedures, thereby boosting the demand for vascular closure devices.
Moreover, the well-established patient care system along with awareness among patients and caregivers regarding the importance of diagnostic and therapeutic interventional procedures is further expected to propel the North American vascular closure devices market growth.
The Asia-Pacific region is expected to witness a significant growth in the vascular closure devices market in the forecast period which can ascribed to the fact that there has been constant efforts in improving healthcare access to the population in the countries in the region and the improvement in disposable income which has further been instrumental in more people opting for healthcare services. All these factors are collectively expected to contribute in the increase in the number of people availing routine diagnostic and treatment services for various diseases such as cardiovascular diseases wherein angiography procedures are majorly used. This is in turn, is expected to drive the demand for vascular closure devices in the region as these devices find application in the sealing of access point entry of the catheter, thereby boosting the growth of the vascular closure devices market in the forecast period.
Vascular Closure Devices Market Key Players:
Some of the key market players operating in the vascular closure devices market include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Cardival Medical, Inc., Merit Medical Systems, Medtronic, Morris Innovative, TZ Medical, Vasorum Ltd, Tricol Biomedical, Vivasure Medical Ltd, Transluminal Technologies, W. L. Gore & Associates, Inc., Meril Life Sciences Pvt. Ltd, Gem srl others.
Recent Developmental Activities in Vascular Closure Devices Market:
In July 2022, Vivasure Medical announced the development of PerQseal® Blue, the new investigational product which is under development. PerQseal Blue is designed specifically for suture less and fully absorbable large-bore venous vessel closure to be used in the percutaneous cardiovascular procedures, such trans-catheter mitral valve repair or replacement (TMVR) and trans-catheter tricuspid valve repair or replacement (TTVR).
In March 2022, CyndRx LLC finalized the pivotal CE Mark trial with the strong clinical outcomes for their vascular closure device AbsorbaSeal(TM) for evaluating the safety and efficacy of this polymer-based device.
In January 2022, Haemonetics Corporation entered into a definitive agreement to acquire Cardiva Medical Inc., a privately owned manufacturer of vascular closure systems.
Key Takeaways from the Vascular Closure Devices Market Report Study
Market size analysis for current vascular closure devices market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vascular closure devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global vascular closure devices market.
Various opportunities available for the other competitor in the vascular closure devices market space.
What are the top performing segments in 2023? How these segments will perform in 2030?
Which is the top-performing regions and countries in the current vascular closure devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for vascular closure devices market growth in the coming future?
Target Audience who can be benefited from this Vascular Closure Devices Market Report Study
Vascular Closure Devices products providers
Research organizations and consulting companies
Vascular Closure Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in vascular closure devices
Various End-users who want to know more about the vascular closure devices market and latest technological developments in the vascular closure devices market.
Frequently Asked Questions for Vascular Closure Devices Market:
A vascular closure device are inserted at the end of a procedure with the aim to stop bleeding that occurs at the access point for the procedure in order to promote hemostasis and improve the ambulation time of patients.
Global Vascular Closure Devices Market was valued at USD 1.11 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030 to reach USD 1.59 billion by 2030.
Factors such as the growing prevalence of cardiovascular disorders, rising prevalence of risk factors associated with the cardiovascular diseases such as obesity and hypertension, increasing geriatric population, and the surge in the popularity of minimally invasive procedures, are expected to drive the vascular closure devices market.
Some of the key market players operating in the vascular closure devices market include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Cardival Medical, Inc., Merit Medical Systems, Medtronic, Morris Innovative, TZ Medical, Vasorum Ltd, Tricol Biomedical, Vivasure Medical Ltd, Transluminal Technologies, W. L. Gore & Associates, Inc., Meril Life Sciences Pvt. Ltd, Gem srl, and others.
North America is expected to dominate the overall Vascular Closure Devices market during the forecast period, 2024 to 2030. North America is predicted to account for the dominant market share because of the high prevalence of cardiovascular diseases and associated risk factors, rising population of the elderly, high awareness among people regarding disease management and ability to afford such devices and among other factors in the region.